Literature DB >> 10841519

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

A Daugherty1, M W Manning, L A Cassis.   

Abstract

Increased plasma concentrations of angiotension II (Ang II) have been implicated in atherogenesis. To examine this relationship directly, we infused Ang II or vehicle for 1 month via osmotic minipumps into mature apoE(-/-) mice. These doses of Ang II did not alter arterial blood pressure, body weight, serum cholesterol concentrations, or distribution of lipoprotein cholesterol. However, Ang II infusions promoted an increased severity of aortic atherosclerotic lesions. These Ang II-induced lesions were predominantly lipid-laden macrophages and lymphocytes; moreover, Ang II promoted a marked increase in the number of macrophages present in the adventitial tissue underlying lesions. Unexpectedly, pronounced abdominal aortic aneurysms were present in apoE(-/-) mice infused with Ang II. Sequential sectioning of aneurysmal abdominal aorta revealed two major characteristics: an intact artery that is surrounded by a large remodeled adventitia, and a medial break with pronounced dilation and more modestly remodeled adventitial tissue. Although no atherosclerotic lesions were visible at the medial break point, the presence of hyperlipidemia was required because infusions of Ang II into apoE(+/+) mice failed to generate aneurysms. These results demonstrate that increased plasma concentrations of Ang II have profound and rapid effects on vascular pathology when combined with hyperlipidemia, in the absence of hemodynamic influences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841519      PMCID: PMC300846          DOI: 10.1172/JCI7818

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.

Authors:  A Daugherty; E Puré; D Delfel-Butteiger; S Chen; J Leferovich; S E Roselaar; D J Rader
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

2.  Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system.

Authors:  F Sugiyama; S Haraoka; T Watanabe; N Shiota; K Taniguchi; Y Ueno; K Tanimoto; K Murakami; A Fukamizu; K Yagami
Journal:  Lab Invest       Date:  1997-06       Impact factor: 5.662

3.  Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation.

Authors:  M I Oliverio; C F Best; H S Kim; W J Arendshorst; O Smithies; T M Coffman
Journal:  Am J Physiol       Date:  1997-04

4.  Normotensive blood pressure in mice with a disrupted renin Ren-1d gene.

Authors:  F Bertaux; W H Colledge; S E Smith; M Evans; N J Samani; C C Miller
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

5.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.

Authors:  P Carmeliet; L Moons; R Lijnen; M Baes; V Lemaître; P Tipping; A Drew; Y Eeckhout; S Shapiro; F Lupu; D Collen
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

6.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.

Authors:  S Hoshida; M Nishida; N Yamashita; J Igarashi; K Aoki; M Hori; T Kuzuya; M Tada
Journal:  Atherosclerosis       Date:  1997-04       Impact factor: 5.162

8.  Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

Authors:  F Diet; R E Pratt; G J Berry; N Momose; G H Gibbons; V J Dzau
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

9.  Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis.

Authors:  M Hernández-Presa; C Bustos; M Ortego; J Tuñon; G Renedo; M Ruiz-Ortega; J Egido
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

10.  Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.

Authors:  R L Davisson; H S Kim; J H Krege; D J Lager; O Smithies; C D Sigmund
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

View more
  495 in total

1.  When it is inflamed, it hurts.

Authors:  R Baliga; J Narula
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  Angiotensin II, atherosclerosis, and aortic aneurysms.

Authors:  B C Berk; J Haendeler; J Sottile
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

3.  Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Authors:  Frank M Davis; Debra L Rateri; Anju Balakrishnan; Deborah A Howatt; Dudley K Strickland; Selen C Muratoglu; Christopher M Haggerty; Brandon K Fornwalt; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

5.  RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease.

Authors:  Toshiro Kitagawa; Hisanori Kosuge; Masaki Uchida; Monica M Dua; Yasunori Iida; Ronald L Dalman; Trevor Douglas; Michael V McConnell
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

6.  TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.

Authors:  Stoyan N Angelov; Jie Hong Hu; Hao Wei; Nathan Airhart; Minghui Shi; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-20       Impact factor: 8.311

7.  Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.

Authors:  Rima Elhage; Pierre Gourdy; Laurent Brouchet; Jacek Jawien; Marie-José Fouque; Catherine Fiévet; Xavier Huc; Yara Barreira; Jean Claude Couloumiers; Jean-François Arnal; Francis Bayard
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice.

Authors:  Jie Zhang; Kiran Chandrashekar; Yan Lu; Yanhua Duan; Phillip Qu; Jin Wei; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

9.  Cathepsin G activity lowers plasma LDL and reduces atherosclerosis.

Authors:  Jing Wang; Sara Sjöberg; Ting-Ting Tang; Katariina Oörni; Wenxue Wu; Conglin Liu; Blandine Secco; Viviane Tia; Galina K Sukhova; Cleverson Fernandes; Adam Lesner; Petri T Kovanen; Peter Libby; Xiang Cheng; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-08-01

10.  Effects of angiotensin II on sustained outward currents in rat ventricular myocytes.

Authors:  Hiroyuki Matsuda; Yasutaka Kurata; Sunao Imanishi; Ryoichi Sato; Toshishige Shibamoto
Journal:  Pflugers Arch       Date:  2003-12-18       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.